Rock Creek Group, LP Abbott Laboratories Transaction History

Rock Creek Group, LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1,624 - $1,948	-17 Reduced 0.99%	1,694 $164,000
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $13,907 - $15,496	-138 Reduced 7.46%	1,711 $186,000
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $35,063 - $41,271	362 Added 24.34%	1,849 $187,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $4,943 - $5,799	-52 Reduced 3.38%	1,487 $163,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $34,059 - $39,434	352 Added 29.65%	1,539 $149,000
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $54,301 - $65,632	-532 Reduced 30.95%	1,187 $129,000
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $34,548 - $42,129	-303 Reduced 14.99%	1,719 $203,000
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $1,270 - $1,556	11 Added 0.55%	2,022 $285,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $124,942 - $138,223	-1,071 Reduced 34.75%	2,011 $238,000
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $30,784 - $36,238	291 Added 10.43%	3,082 $357,000
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $190,470 - $224,402	-1,750 Reduced 38.54%	2,791 $334,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $5,670 - $6,178	-54 Reduced 1.18%	4,541 $497,000
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $29,141 - $35,390	-318 Reduced 6.47%	4,595 $500,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $376,188 - $481,474	4,913 New	4,913 $449,000
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $1.74 Million - $1.97 Million	-26,590 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $1.62 Million - $1.95 Million	26,590 New	26,590 $1.95 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.